"During this time, I realized there was something scarier than death. I thought I might be stuck like this forever." ...

COVID-19, even in mild cases, is linked to changes in Alzheimer’s disease-related brain biomarkers comparable to four years ...

Findings indicate a sharp drop in immunity after Omicron infection, stressing the necessity for updated vaccines to enhance ...

This article examines viral and non-viral vectors in gene therapy, highlighting their mechanisms, advantages, and limitations ...

About Veru Inc. Veru is a late clinical stage biopharmaceutical company focused on developing novel medicines for the treatment of cardiometabolic diseases, oncology, and ARDS. The Company’s drug ...

Olivia Lenhart has remained on a ventilator since last month, when she was taken to the hospital with low oxygen levels and labored breathing.

The following is a summary of “Identification of patient demographic, clinical, and SARS-CoV-2 genomic factors associated with severe COVID-19 using supervised machine learning: a retrospective ...

Studies indicate that around 70% of patients recover well with proper treatment and rehabilitation and treatments like plasma ...

As Maharashtra reports first death from the neurological condition, doctors explain the rise in cases, symptoms to watch for, and steps to prevent Guillain-Barre syndrome ...

Guillain-Barré syndrome (GBS) is a rare autoimmune disorder where the immune system attacks the peripheral nervous system, affecting muscle control and sensory signals.

A newly developed vaccine against a group of viruses including SARS-CoV-2 is producing promising results in mice, part of the ...

Tingling, weakness of hand-grip or foot drop could signal Guillain-Barré Syndrome (GBS), said health experts on Monday, even as the reported cases spike in Pune ...